USD 10.56
(6.99%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 | 62.37 Million USD | 4.76% |
2022 | 59.54 Million USD | 9.3% |
2021 | 54.47 Million USD | 21.11% |
2020 | 44.98 Million USD | 18.42% |
2019 | 37.98 Million USD | 79.47% |
2018 | 21.16 Million USD | 76.21% |
2017 | 12.01 Million USD | 18.58% |
2016 | 10.12 Million USD | -20.13% |
2015 | 12.68 Million USD | -1.92% |
2014 | 12.93 Million USD | 17.68% |
2013 | 10.98 Million USD | 7.35% |
2012 | 10.23 Million USD | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 Q2 | 59.23 Million USD | -0.42% |
2024 Q1 | 59.47 Million USD | -4.65% |
2023 Q4 | 62.37 Million USD | -1.44% |
2023 Q1 | 62.94 Million USD | 5.72% |
2023 Q2 | 63.74 Million USD | 1.26% |
2023 Q3 | 63.28 Million USD | -0.71% |
2023 FY | 62.37 Million USD | 4.76% |
2022 Q3 | 56.76 Million USD | 1.82% |
2022 Q4 | 59.54 Million USD | 4.89% |
2022 FY | 59.54 Million USD | 9.3% |
2022 Q1 | 55.32 Million USD | 1.56% |
2022 Q2 | 55.75 Million USD | 0.77% |
2021 Q4 | 54.47 Million USD | 4.95% |
2021 Q3 | 51.9 Million USD | 1.5% |
2021 FY | 54.47 Million USD | 21.11% |
2021 Q2 | 51.14 Million USD | 17.31% |
2021 Q1 | 43.59 Million USD | -3.09% |
2020 Q4 | 44.98 Million USD | 5.51% |
2020 FY | 44.98 Million USD | 18.42% |
2020 Q3 | 42.63 Million USD | 1.25% |
2020 Q2 | 42.1 Million USD | 6.62% |
2020 Q1 | 39.49 Million USD | 3.96% |
2019 Q4 | 37.98 Million USD | 0.03% |
2019 FY | 37.98 Million USD | 79.47% |
2019 Q1 | 31.86 Million USD | 50.57% |
2019 Q2 | 33.73 Million USD | 5.87% |
2019 Q3 | 37.97 Million USD | 12.56% |
2018 Q4 | 21.16 Million USD | 14.6% |
2018 FY | 21.16 Million USD | 76.21% |
2018 Q1 | 17.18 Million USD | 43.07% |
2018 Q2 | 17.44 Million USD | 1.5% |
2018 Q3 | 18.46 Million USD | 5.88% |
2017 Q2 | 11.54 Million USD | 5.14% |
2017 Q1 | 10.98 Million USD | 8.43% |
2017 Q4 | 12.01 Million USD | 9.64% |
2017 FY | 12.01 Million USD | 18.58% |
2017 Q3 | 10.95 Million USD | -5.14% |
2016 Q3 | 9.86 Million USD | -6.42% |
2016 Q1 | 11.31 Million USD | -10.75% |
2016 Q2 | 10.54 Million USD | -6.87% |
2016 FY | 10.12 Million USD | -20.13% |
2016 Q4 | 10.12 Million USD | 2.68% |
2015 FY | 12.68 Million USD | -1.92% |
2015 Q2 | 11.87 Million USD | -6.25% |
2015 Q1 | 12.67 Million USD | -2.02% |
2015 Q4 | 12.68 Million USD | 9.07% |
2015 Q3 | 11.62 Million USD | -2.11% |
2014 Q3 | 11.41 Million USD | -1.4% |
2014 FY | 12.93 Million USD | 17.68% |
2014 Q4 | 12.93 Million USD | 13.25% |
2014 Q2 | 11.58 Million USD | 0.0% |
2013 Q4 | 10.98 Million USD | 0.0% |
2013 FY | 10.98 Million USD | 7.35% |
2012 FY | 10.23 Million USD | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
Acadia Healthcare Company, Inc. | 2.47 Billion USD | 97.476% |
Addus HomeCare Corporation | 317.73 Million USD | 80.367% |
AirSculpt Technologies, Inc. | 129.56 Million USD | 51.853% |
Amedisys, Inc. | 940.38 Million USD | 93.367% |
American Oncology Network, Inc. | 368.72 Million USD | 83.083% |
Astrana Health, Inc. | 522.59 Million USD | 88.064% |
Aveanna Healthcare Holdings Inc. | 1.76 Billion USD | 96.465% |
IMAC Holdings, Inc. | 1.89 Million USD | -3188.702% |
biote Corp. | 191.84 Million USD | 67.484% |
Cryo-Cell International, Inc. | 72.25 Million USD | 13.665% |
Cross Country Healthcare, Inc. | 205.92 Million USD | 69.708% |
COMPASS Pathways plc | 50.24 Million USD | -24.155% |
DocGo Inc. | 185.28 Million USD | 66.333% |
The Ensign Group, Inc. | 2.68 Billion USD | 97.673% |
Healthcare Services Group, Inc. | 346.56 Million USD | 82.001% |
InnovAge Holding Corp. | 247.85 Million USD | 74.832% |
Assure Holdings Corp. | 22.84 Million USD | -173.005% |
LifeStance Health Group, Inc. | 804.27 Million USD | 92.244% |
Mobile-health Network Solutions Class A Ordinary Shares | 3.81 Million USD | -1536.744% |
ModivCare Inc. | 1.61 Billion USD | 96.128% |
NewGenIvf Group Limited | 1.24 Million USD | -4924.748% |
Novo Integrated Sciences, Inc. | 11.06 Million USD | -463.803% |
Option Care Health, Inc. | 1.9 Billion USD | 96.728% |
P3 Health Partners Inc. | 427.3 Million USD | 85.402% |
P3 Health Partners Inc. | 427.3 Million USD | 85.402% |
The Pennant Group, Inc. | 394.17 Million USD | 84.175% |
Surgery Partners, Inc. | 3.65 Billion USD | 98.294% |
Syra Health Corp. Class A Common Stock | 910.07 Thousand USD | -6754.29% |
Talkspace, Inc. | 23.57 Million USD | -164.598% |
Talkspace, Inc. | 23.57 Million USD | -164.598% |
The Oncology Institute, Inc. | 162.39 Million USD | 61.588% |
The Oncology Institute, Inc. | 162.39 Million USD | 61.588% |